RPA-CRISPR / Cas12a-based human adenovirus 7 type detection system, detection kit, detection method and application of RPA-CRISPR / Cas12a-based human adenovirus 7 type detection system
Through the RPA-CRISPR/Cas12a-based human adenovirus type 7 detection system, the accuracy of human adenovirus type 7 detection is solved, achieving high accuracy of high-quality use of specific crRNA and RPA primer pairs and combined with fluorescent or biotin-labeled probes. Sensitivity and specificity meet the needs of fast and accurate detection.
Patent Information
- Application Number
- CN202411059130.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art cannot accurately distinguish and detect human adenovirus type 7, especially in subpopulation B, resulting in diagnostic errors and treatment delays.
Using a human adenovirus type 7 detection system based on RPA-CRISPR/Cas12a, the detection method is constructed to achieve high sensitivity and specificity detection by designing specific crRNA and RPA primer pairs, combining fluorescent or biotin-labeled probes.
Accurate detection of human adenovirus type 7 is achieved, with a detection limit of 101copies/μL, which has good specificity and can quickly and accurately identify human adenovirus type 7 in a simulated real environment, avoiding cross-reaction with other viruses. Meet the needs of instant on-site inspection.
Smart Images

Figure CN118910328A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of rapid detection of pathogenic microorganisms, and specifically relates to a human adenovirus type 7 detection system, a detection kit, a detection method and applications thereof based on RPA-CRISPR / Cas12a. Background Art
[0002] Human adenovirus (HAdV) is a non-enveloped double-stranded DNA virus that mainly causes respiratory diseases. It can also infect the digestive tract, urinary tract, and eyes and cause diseases. Its pathogenicity and clinical symptoms are closely related to its type. According to different biological characteristics, the International Committee on Taxonomy of Viruses (ICTV) divides it into 7 subgenera from A to G. A, F and G mainly cause digestive tract infections and diarrhea, C, E and some B subgenera mainly cause respiratory diseases, other B subgenera mainly cause urinary tract infections, and D subgenera mainly cause keratitis and conjunctivitis. Human adenovirus can cause a variety of human diseases. Among them, the human adenoviruses related to respiratory diseases are mainly B subgenera (HAdV-3, 7, 11, 14, 16, 21, 50, 55), C subgenera (HAdV-1, 2, 5, 6, 57) and E subgenera (HAdV-4). The B subgenera that cause common respiratory diseases are mainly HAdV-3, 7, 11, 14 and 55. Reports show that HAdV infection is mainly concentrated in the 3-6 year old population, with a median age of 4 years and 6 months. Children under 5 years old account for 58.73%. The detection rate is highest in preschool children, followed by infants and school-age children. The main route of transmission is through air droplets. Therefore, accurate identification and differentiation of human adenovirus is of great significance for determining and optimizing treatment plans and inhibiting the spread of pathogens.
[0003] Human adenovirus is a DNA virus. Human adenovirus type 7 HAdV-7 belongs to group B among its 7 subgroups. It is a common pathogen causing acute respiratory infections worldwide. Infections caused by HAdV-7 can account for about 20% of all human adenovirus infections and are relatively serious. HAdV-7 infected people are its main source of infection, mainly through droplets. The respiratory secretion aerosols discharged by infected people through coughing, sneezing, etc. can stay in the air for more than 30 minutes. In addition, it can also be transmitted through fecal-oral transmission and contact transmission. Infants, students, and soldiers are susceptible to it. HAdV-7 patients are prone to co-infection with other pathogens. If there is a lack of rapid and accurate detection methods, they are easily misdiagnosed as other diseases by clinicians and delayed treatment. It is very important to develop a rapid and accurate HAdV-7 detection method for clinical use. The traditional virus culture serum typing method can no longer meet the timeliness requirements of clinical practice. Molecular biological typing methods have become the main method for HAdV typing detection.
[0004] The clustered regularly interspaced short palindromic repeats (CRISPR) technology developed in recent years has been widely used in point-of-care testing (POCT) due to its excellent detection mechanism, rapid reaction efficiency, excellent detection sensitivity, and simple external reaction conditions. The CRISPR-Cas system composed of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas protein) is an acquired immune system in bacteria or archaea. The CRISPR-Cas system can be used not only for gene editing, but also for nucleic acid detection of pathogens. Cas12a protein has trans-cutting activity. Under the guidance of crRNA, Cas12a protein specifically binds to the targeted double-stranded DNA (dsDNA) and activates its trans-cutting activity, indiscriminately cutting non-specific single-stranded DNA (ssDNA). By modifying the fluorescent groups and quenching groups at both ends of ssDNA, a fluorescent signal will be emitted when the ssDNA probe is cleaved. Therefore, the CRISPR-Cas12a system can be used as a tool for nucleic acid detection.
[0005] Recombinase polymerization reaction (RPA) is an isothermal amplification strategy that uses recombinase to separate dsDNA targets and catalyze the hybridization of primers with homologous template sequences, thereby initiating strand exchange at homologous sites. The resulting structure is stabilized by ssDNA binding proteins to prevent primer displacement caused by branch migration. Subsequently, DNA polymerase recognizes the 3' end of the primer left by the recombinase decomposition and initiates the primer extension reaction. The cyclic repetition of this process leads to exponential amplification of the target sequence. Within 40 minutes, millions of target copies accumulate at low temperatures (37-42°C), and the detection limit is as low as a single target copy. In addition to the detection methods used in other isothermal techniques, RPA can be combined with FRET-based fluorescent probes and lateral flow strip sensing systems to reduce background noise and achieve instrument-free result display, respectively, for the detection of pathogens and viruses. RPA is an isothermal amplification technology with low requirements for instruments and equipment, no need for precision instruments, and has the advantages of rapid response, high sensitivity, strong specificity, low temperature operation, wide applicability, flexible reagent form and diverse detection forms. It can be an alternative to traditional PCR methods.
[0006] A Chinese patent with publication number CN113355324A and application date July 13, 2021 discloses a probe, a kit and a method of use for detecting human adenovirus type 7. The kit is a human adenovirus type 7 nucleic acid detection kit based on the MIRA fluorescence method, wherein the MIRA primer is designed based on the specific sequence of the adenovirus type 7 hexon gene, but the conserved sequence of the human adenovirus type 7 hexon gene amplified by this invention is a sequence known in the prior art, and no technical inspiration for designing a new human adenovirus type 7 crRNA for detection is provided; a Chinese patent with publication number CN113502351A and application date July 13, 2021 discloses a probe, a kit and a method of use for detecting human adenovirus type 7. The kit is a human adenovirus type 7 nucleic acid detection kit based on the MIRA fluorescence method, wherein the MIRA primer is designed based on the specific sequence of the adenovirus type 7 hexon gene, but the conserved sequence of the human adenovirus type 7 hexon gene amplified by this invention is a sequence known in the prior art, and no technical inspiration for designing a new human adenovirus type 7 crRNA for detection is provided; A Chinese patent on June 29 disclosed a crRNA and a method for using CRISPR-Cas12a to detect human adenovirus nucleic acid. The CRISPR-Cas12a technology is simple, easy and fast, and the detection of sample nucleic acid can be completed in one step. Moreover, because it is combined with PCR amplification technology, that is, the PCR-Cas12a detection technology amplifies the PCR nucleic acid amplification signal, the detection method has extremely high detection sensitivity. However, the sensitivity of this detection method is mainly aimed at the main prevalent human adenovirus B subgroup, and it is impossible to make accurate distinctions between human adenovirus types 3, 7, 14, and 55 in the B subgroup.
[0007] Therefore, the highly sensitive and specific nucleic acid detection technology based on the CRISPR-Cas12a system will play a huge role in the field of pathogen diagnosis. Designing a highly sensitive and specific PCR-Cas12a nucleic acid detection technology for human adenovirus type 7 in subgroup B will provide a new method for the detection and monitoring of human respiratory adenovirus, which has important application potential and research significance. Summary of the invention
[0008] In order to solve the problems existing in the prior art, the present invention provides a human adenovirus type 7 detection system, a detection kit, a detection method and applications thereof based on RPA-CRISPR / Cas12a. The detection system and the detection method are easy to operate and have the characteristics of high sensitivity and high specificity for human adenovirus type 7.
[0009] The technical solution of the present invention is as follows:
[0010] One of the objects of the present invention is to provide a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a, wherein the detection system comprises a Cas12a-crRNA functional complex, an RPA primer pair and a probe for amplifying a human adenovirus type 7 specific sequence;
[0011] The Cas12a-crRNA functional composition is formed by the combination of crRNA and Cas12a, and the nucleotide sequence of the crRNA is SEQ ID NO: 1.
[0012] Furthermore, the RPA upstream primer is a single-stranded DNA molecule whose nucleotide sequence is SEQ ID NO:2, and the RPA downstream primer is a single-stranded DNA molecule whose nucleotide sequence is SEQ ID NO:3.
[0013] Furthermore, the probe is a single-stranded DNA probe doubly labeled with a fluorescent group and a quencher group or a single-stranded DNA probe doubly labeled with a fluorescent group and biotin.
[0014] Furthermore, the 5' end of the single-stranded DNA probe dual-labeled with a fluorescent group and a quenching group is labeled with a fluorescent group FAM, and the 3' end is labeled with a quenching group BHQ1; the nucleotide sequence of the probe is shown in SEQ ID NO: 4;
[0015] The 5' end of the single-stranded DNA probe dual-labeled with a fluorescent group and biotin is labeled with a fluorescent group
[0016] FAM, 3' end labeled with biotin; the nucleotide sequence of the probe is shown in SEQ ID NO:5.
[0017] The second object of the present invention is to provide a method for constructing a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a, comprising the following steps:
[0018] S1. According to claim 1, the crRNA sequence synthesizes the corresponding single-stranded DNA transcription template, and prepares double-stranded DNA as an in vitro transcription template by annealing;
[0019] S2. Prepare the transcription system, incubate the transcription system in a 37°C incubator overnight, recover crRNA with an RNA purification kit after enzyme digestion, and then recombine with Cas12a to obtain a Cas12a-crRNA functional complex;
[0020] S3. Use RPA primers to perform isothermal amplification reaction on the nucleic acid of the sample to be tested to obtain RPA amplification products, and then add probes and Cas12a-crRNA functional complexes to perform cleavage reactions to construct a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a.
[0021] Further, the annealing system is as follows:
[0022] Upstream DNA single strand: 10 μL;
[0023] Downstream single-stranded DNA: 10 μL.
[0024] Furthermore, the transcription system is as follows:
[0025] Transcription template: 2 μL;
[0026] rNTP: 1.6 μL;
[0027] 10x transcription buffer: 2 μL;
[0028] Nuclease free water: 12.4μL;
[0029] Nuclease inhibitor: 1 μL;
[0030] T7 RNA polymerase: 1 μL.
[0031] The third object of the present invention is to provide a human adenovirus type 7 detection kit based on RPA-CRISPR / Cas12a, wherein the kit comprises a human adenovirus type 7 detection system, a virus lysis reagent, a component for RPA reaction, and a component for crRNA transcription.
[0032] A fourth object of the present invention is to provide a method for detecting human adenovirus type 7 based on RPA-CRISPR / Cas12a, wherein the detection method is based on non-diagnostic purposes and comprises the following steps:
[0033] (1) using the detection kit as claimed in claim 5 to detect the sample to be tested, and lysing the virus to obtain the nucleic acid of the sample to be tested;
[0034] (2) mixing the sample nucleic acid to be tested with the RPA primer pair for isothermal amplification reaction to obtain an RPA amplification product, and then adding a functional complex and a probe to form an RPA-CRISPR / Cas12a detection system and performing a cleavage reaction therein to obtain a reaction product;
[0035] (3) Detecting the reaction product and determining whether the sample to be tested contains human adenovirus type 7 based on the detection result.
[0036] Furthermore, when the detection kit uses a single-stranded DNA probe dual-labeled with a fluorescent group and a quenching group, the detection method in step (3) is to place the reaction product into an ELISA instrument for fluorescence measurement, observe the fluorescence and read the result;
[0037] When the detection kit uses a single-stranded DNA probe dual-labeled with a fluorescent group and biotin, the detection method in step (3) is to drop the reaction product on the sample application end of the immunochromatographic test paper and observe the band interpretation results.
[0038] A fifth object of the present invention is to provide an application of a human adenovirus type 7 detection method based on RPA-CRISPR / Cas12a in detecting or identifying human adenovirus type 7 for non-diagnostic purposes.
[0039] Compared with the prior art, the beneficial effects of the present invention are:
[0040] 1. Aiming at the current application demand for accurate detection of human adenovirus type 7, the present invention designs a detection system and a detection kit for human adenovirus type 7 based on RPA-CRISPR / Cas12a nucleic acid detection technology, and provides a corresponding detection method. The detection method can reach a detection limit of 10 when the detection method is carried out under simulated real environmental conditions, that is, using a healthy person's oropharyngeal swab and a pseudovirus mixed sample for detection. 1 The detection level of copies / μL was low, and in the specificity verification, there was no cross reaction with monkeypox virus pseudovirus, human adenovirus type 7 pseudovirus, and new coronavirus pseudovirus, showing good specificity. Compared with the existing human adenovirus detection reagents and methods, it has multiple technical advantages such as simple operation, rapid response, and excellent sensitivity, which can meet the needs of on-site instant detection applications.
[0041] 2. The present invention is based on RPA-CRISPR / Cas12a nucleic acid detection technology. Through design, construction and screening, a new crRNA for human adenovirus type 7 is finally provided, and a Cas12a-crRNA functional complex, an RPA primer pair and a probe for amplifying a specific sequence of human adenovirus type 7 are designed based on this. The constructed detection system can realize high-sensitivity and high-specific detection of human adenovirus type 7 by activating Cas12a, overcoming the defect that human adenovirus type 7 cannot be further detected in the existing human adenovirus B subgenus identification technology. Compared with other pathogenic microorganism detection methods that are prone to interference in clinics and laboratories, the detection method of the present invention has extremely high specificity and has important application value in the field of detection and identification of human adenovirus type 7.
[0042] 3. The detection kit disclosed in the present invention can dual-specifically identify human adenovirus type 7, and can be placed in an ELISA instrument to detect human adenovirus type 7 by fluorescence measurement. If fluorescence appears, it indicates that the sample to be tested is infected with bacteria, and if no fluorescence appears, it indicates that the sample to be tested is not infected with bacteria. FAM-biotin probe can also be used for immunochromatographic detection. In negative samples, the gold-labeled anti-biotin antibody fully combines with the high-concentration FAM-biotin probe, and the conjugate is intercepted by the anti-FAM antibody in the control band. In positive samples, the FAM-biotin probe is cut and separated, and the conjugate of the gold-labeled anti-biotin antibody and biotin accumulates in the detection band, while the accumulation in the control band is reduced, thereby realizing real-time visual detection of human adenovirus type 7. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Figure 1 This is a fluorescence signal monitoring diagram of crRNA in the human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a described in Example 1 of the present invention;
[0044] Figure 2 This is a fluorescence detection result diagram of the human adenovirus type 7 detection kit based on RPA-CRISPR / Cas12a described in Example 2 of the present invention;
[0045] Figure 3 This is a diagram of the application of the human adenovirus type 7 detection kit based on RPA-CRISPR / Cas12a described in Example 3 of the present invention on an immunochromatographic test paper;
[0046] Figure 4 This is a graph showing the detection limit test results of the human adenovirus type 7 detection method based on RPA-CRISPR / Cas12a described in the performance test of the present invention;
[0047] Figure 5 This is a graph showing the specificity test results of the human adenovirus type 7 detection method based on RPA-CRISPR / Cas12a described in the performance test of the present invention. DETAILED DESCRIPTION
[0048] The present invention is further described below in conjunction with preferred embodiments. The endpoints of the ranges disclosed in the present invention and any values are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, and these numerical ranges should be deemed to be specifically disclosed herein.
[0049] The experimental methods in the following examples, unless otherwise specified, are conventional methods and are performed according to the techniques or conditions described in the literature in the art or according to the product instructions.
[0050] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0051] The monkeypox virus pseudovirus in the following examples is a product of Sangon Biotech (Shanghai) Co., Ltd.
[0052] The human adenovirus type 7 pseudovirus in the following examples is a product of Sangon Biotech (Shanghai) Co., Ltd.
[0053] The human novel coronavirus pseudovirus in the following embodiments is a product of Sangon Biotech (Shanghai) Co., Ltd.
[0054] In the following examples, Cas12a protein and crRNA transcription template DNA were commissioned to be synthesized by Shangya Biotechnology Co., Ltd.
[0055] In the following examples, the RPA amplification primer pairs were commissioned to be synthesized by Shangya Biotechnology Co., Ltd.
[0056] The virus lysis solution in the following examples is a product of Nanjing Novozyme Biotechnology Co., Ltd.
[0057] In the following examples, T7 RNA polymerase (NEB) and RNA purification kit were products of Sangon Biotechnology (Shanghai) Co., Ltd.
[0058] In the following examples, the DNA fluorescent probes were commissioned to be synthesized by Shangya Biotechnology Co., Ltd.
[0059] The immunochromatographic test strips in the following examples are products of Suzhou Xinda Gene Co., Ltd.
[0060] Example 1
[0061] This embodiment provides a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a, and the construction method thereof is as follows:
[0062] (1) Design and screening of crRNA
[0063] The specific sequence of human adenovirus type 7 was determined through the National Center for Biotechnology Information (NCBI) database of the United States, and the corresponding crRNA was designed for each specific sequence to obtain a series of candidate crRNA nucleotide sequences. The candidate crRNA was compared online in the National Center for Biotechnology Information (NCBI) of the United States to obtain a crRNA with higher specificity. The specific nucleotide information SEQ ID NO: 1 is shown in Table 1:
[0064] Table 1 Nucleotide sequence of crRNA
[0065] Bacteria Serial Number crRNA sequence F3L HAdV-7 SEQ ID NO:1 guaauuucuacuaaguguagauuuucaaaaaccgucgguguc
[0066] (2) Preparation of crRNA
[0067] The corresponding single-stranded transcription template DNA is synthesized according to the selected crRNA sequence, and double-stranded DNA is prepared as an in vitro transcription template by annealing. The annealing system is as follows:
[0068] Upstream DNA single strand 10μL Downstream DNA single strand 10μL Total volume 20μL
[0069] (3) Configure the transcription system
[0070] The transcription system was placed in a 37°C incubator for overnight incubation, and crRNA was recovered using an RNA purification kit after enzyme digestion, and then complexed with Cas12a to obtain a Cas12a-crRNA functional complex;
[0071] Transcription template 2μL rNTP 1.6μL 10x transcription buffer 2μL Enzyme-free water 12.4μL Ribozyme inhibitors 1μL T7 RNA polymerase 1μL Total volume 20μL
[0072] (4) RNA purification
[0073] RPA primers were used to perform isothermal amplification reaction on the nucleic acid of the sample to be tested to obtain RPA amplification products, and then probes were added to the Cas12a-crRNA functional complex for cleavage reaction to construct a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a, where the CRISPR-Cas12a reaction system is as follows:
[0074] Components Storage concentration Final concentration Volume (μL) Cas12a protein 1 μM 25nM 0.5 crRNA <![CDATA[a1]]> 50nM <![CDATA[b1]]> Linear specific sequence DNA <![CDATA[c1 nM]]> d1 <![CDATA[e1]]> FAM-BHQ1 probe 10μM 500nM 1 RNase inhibitors 40 U / μL 1U / μL 2 Enzyme-free water — — <![CDATA[16.5-b1-c1]]> Total volume — — 20
[0075] Note: a1 is the storage concentration of crRNA. The final concentration of 50nM is determined experimentally. The volume of crRNA added is calculated as b1=20×50 / a1; c1 is the storage concentration of linear DNA. The final concentration d1 is determined experimentally. The volume of DNA added is calculated as e1=20×d1 / c1.
[0076] Figure 1 This is the fluorescence signal monitoring result of crRNA 1 in this example. It can be seen from the figure that the screened crRNA can recognize specific sequences and release fluorescence in the reaction system when acting together with CRISPR-Cas12a.
[0077] Example 2
[0078] The present embodiment provides a human adenovirus type 7 detection kit based on RPA-CRISPR / Cas12a, including a human adenovirus type 7 detection system, a virus lysis reagent, a component for RPA reaction, and a component for crRNA transcription.
[0079] Among them, for the specific sequence complementary to crRNA, the RPA primer pair was designed by performing RPA isothermal amplification reaction by the National Center for Biotechnology Information (NCBI), and the specific nucleotide information is shown in Table 2 below:
[0080] Table 2 Nucleotide sequences of RPA primer pairs
[0081]
[0082]
[0083] The probe used in the human adenovirus type 7 detection system is a single-stranded DNA probe double-labeled with a fluorescent group and a quenching group, the 5' end of the probe is labeled with a fluorescent group (FAM), and the 3' end is labeled with a quenching group (BHQ1); the nucleotide sequence of the probe is shown in Table 3:
[0084] Table 3 Nucleotide sequences of fluorescence quenching probes
[0085] sequence name Sequence information (5'-3') ssDNA FQ-Probe (SEQ ID NO:4) FAM-ttatt-BHQ1
[0086] Example 3
[0087] This embodiment provides a method for detecting human adenovirus type 7 based on RPA-CRISPR / Cas12a, comprising the following steps:
[0088] (1) Dilute to 10 1 The human adenovirus type 7 sample with a concentration of 100 copies / μL was lysed to obtain genomic DNA, and the genomic DNA was used as a template and mixed with the RPA primer pair for isothermal amplification reaction to obtain the RPA amplification product;
[0089] (2) Add Cas12a-crRNA functional complex and fluorescent biotin probe (nucleotide sequence is shown in Table 4) to the RPA amplification product to form an RPA-CRISPR / Cas12a detection system and perform a cleavage reaction therein to obtain a reaction product, wherein the steps of RPA isothermal amplification, Cas12a-crRNA incubation, and Cas12a reaction are all performed by hand-held operation mode;
[0090] Table 4 Nucleotide sequences of fluorescent biotin probes
[0091] sequence name Sequence information (5'-3') ssDNA FB-Probe (SEQ ID NO:5) FAM-ttatt-Biotin
[0092] (3) Add the above reaction product liquid dropwise to the sample application end of the immunochromatographic test paper and observe the strip reading results.
[0093] Test results such as Figure 3 As shown in the figure, it can be clearly seen that the C line of the immunochromatographic test paper is obvious while the T line is not colored, and the target sequence of human adenovirus type 7 in the test sample is accurately detected, indicating that the detection scheme described in this embodiment has fast speed, high sensitivity, strong specificity, and portability.
[0094] Performance Testing
[0095] 1. Specificity test
[0096] The monkeypox virus pseudovirus, human adenovirus type 7 pseudovirus, and new coronavirus pseudovirus were lysed to obtain genomic DNA, and the genomic DNA was used as a template to amplify using the above-mentioned RPA primer pair to obtain an amplification product; the Cas12a-crRNA functional complex and the fluorescent biotin probe were added to the RPA amplification product to form an RPA-CRISPR / Cas12a detection system and a cleavage reaction was performed therein, and the obtained reaction product was dripped onto the sample application end of the immunochromatographic test paper, and the detection result was as follows: Figure 5 shown.
[0097] The experimental results showed that except for the target virus human adenovirus type 7, the other viruses were not detected. This shows that the human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a has good specificity and can accurately detect the target virus without interference from other viruses.
[0098] 2. Detection limit test
[0099] The human adenovirus type 7 pseudovirus sample to be tested was diluted in a gradient manner, and the diluted samples were added to the RPA isothermal amplification system respectively, mixed with the Cas12a-crRNA functional complex and the fluorescent quenching probe, placed in an ELISA instrument for cleavage reaction, and the results were interpreted after fluorescent detection of the reaction products.
[0100] Test results such as Figure 4 As shown: When the virus concentration is 3.3×10 0 When the virus concentration was 3.3×10 3 , 3.3×10 2 Even 3.3×10 1 When the detection system was 10 copies / μL, it showed good detection ability and successfully identified the virus. This finding shows that under simulated real environmental conditions, that is, when using healthy people's oropharyngeal swabs and fake virus mixed samples for testing, the detection limit of the detection system can reach 10 1 The level of copies / μL.
[0101] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.
Claims
1. A human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a, characterized in that: The detection system includes a Cas12a-crRNA functional complex, an RPA primer pair and a probe for amplifying a human adenovirus type 7 specific sequence; The Cas12a-crRNA functional composition is formed by the combination of crRNA and Cas12a, and the nucleotide sequence of the crRNA is SEQ ID NO:
1.
2. A human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a according to claim 1, characterized in that: The RPA upstream primer is a single-stranded DNA molecule whose nucleotide sequence is SEQ ID NO: 2, and the RPA downstream primer is a single-stranded DNA molecule whose nucleotide sequence is SEQ ID NO:
3.
3. A human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a according to claim 1, characterized in that: The probe is a single-stranded DNA probe double-labeled with a fluorescent group and a quenching group or a single-stranded DNA probe double-labeled with a fluorescent group and biotin.
4. A human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a according to claim 3, characterized in that: The 5' end of the single-stranded DNA probe dual-labeled with a fluorescent group and a quenching group is labeled with a fluorescent group FAM, and the 3' end is labeled with a quenching group BHQ1; the nucleotide sequence of the probe is shown in SEQ ID NO: 4; The 5' end of the fluorescent group and biotin double-labeled single-stranded DNA probe is labeled with a fluorescent group FAM, and the 3' end is labeled with biotin Biotin; the nucleotide sequence of the probe is shown in SEQ ID NO:
5.
5. A method for constructing a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a as described in any one of claims 1 to 4, characterized in that: The following steps are involved: S1. According to claim 1, the crRNA sequence synthesizes the corresponding single-stranded DNA transcription template, and prepares double-stranded DNA as an in vitro transcription template by annealing; S2. Prepare the transcription system, incubate the transcription system in a 37°C incubator overnight, recover crRNA with an RNA purification kit after enzyme digestion, and then recombine with Cas12a to obtain a Cas12a-crRNA functional complex; S3. Use RPA primers to perform isothermal amplification reaction on the nucleic acid of the sample to be tested to obtain RPA amplification products, and then add probes and Cas12a-crRNA functional complexes to perform cleavage reactions to construct a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a.
6. A method for constructing a human adenovirus type 7 detection system based on RPA-CRISPR / Cas12a according to claim 5, characterized in that: The annealing system is as follows: Upstream DNA single strand: 10 μL; Downstream single-stranded DNA: 10 μL; The transcription system is as follows: Transcription template: 2 μL; rNTP: 1.6 μL; 10x transcription buffer: 2 μL; Nuclease free water: 12.4μL; Nuclease inhibitor: 1 μL; T7 RNA polymerase: 1 μL.
7. A human adenovirus type 7 detection kit based on RPA-CRISPR / Cas12a, characterized in that: The kit comprises the human adenovirus type 7 detection system according to any one of claims 1 to 4, a virus lysis reagent, a component for RPA reaction, and a component for crRNA transcription.
8. A method for detecting human adenovirus type 7 based on RPA-CRISPR / Cas12a, characterized in that: The detection method is based on non-diagnostic purposes and includes the following steps: (1) using the detection kit as claimed in claim 5 to detect the sample to be tested, and lysing the virus to obtain the nucleic acid of the sample to be tested; (2) mixing the sample nucleic acid to be tested with the RPA primer pair for isothermal amplification reaction to obtain an RPA amplification product, and then adding a functional complex and a probe to form an RPA-CRISPR / Cas12a detection system and performing a cleavage reaction therein to obtain a reaction product; (3) Detecting the reaction product and determining whether the sample to be tested contains human adenovirus type 7 based on the detection result.
9. A method for detecting human adenovirus type 7 based on RPA-CRISPR / Cas12a according to claim 8, characterized in that: When the detection kit uses a single-stranded DNA probe dual-labeled with a fluorescent group and a quenching group, the detection method in step (3) is to place the reaction product into an ELISA instrument for fluorescence measurement, observe the fluorescence and read the result; When the detection kit uses a single-stranded DNA probe dual-labeled with a fluorescent group and biotin, the detection method in step (3) is to drop the reaction product on the sample application end of the immunochromatographic test paper and observe the band interpretation results.
10. An application of the human adenovirus type 7 detection method based on RPA-CRISPR / Cas12a as described in claim 8 or 9 in detecting or identifying human adenovirus type 7 for non-diagnostic purposes.
Citation Information
Patent Citations
RPA method for detecting 7 type human adenovirus, special primer, probe and application thereof
CN109504803A
Primer group for amplifying or detecting human adenovirus DNA and application thereof
CN113416798A
crRNA and method for detecting human adenovirus nucleic acid by using CRISPR-Cas12a
CN113502351A
Adenovirus detection typing kit and method
CN117106969A
Rapid adenovirus detection method based on One-Tube RPA-CRISPR / Cas12a
CN117265185A
